Perennial allergic rhinitis and nasal hyperreactivity

American Journal of Rhinology

Volumn 12, Issue 1, 1998, Pages 33-35

  Gerth Van Wijk, R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE; HISTAMINE; INTERLEUKIN 5; LEVOCABASTINE; SALMETEROL;

ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; COMORBIDITY; CONFERENCE PAPER; ECZEMA; EOSINOPHIL; HUMAN; NOSE; PERENNIAL RHINITIS; QUALITY OF LIFE;

EID: 0031947139     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065898782103034     Document Type: Conference Paper

References (19)

1. Horn BR, Robin ED, Theodore J, Kessel AV. Total eosinophil counts in the management of bronchial asthma. N Engl J Med 292:1152-1155, 1975.
2. Taylor KJ, Luksza AR. Peripheral blood eosinophil counts and bronchial responsiveness. Thorax 42:452-456, 1987.
3. Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial asthma. Am Rev Respir Dis 145:1469-1476, 1992.
4. Klementsson H, Venge P, Anderson M, Pipkorn U. Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. In: Klementsson H, Ed. Eosinophil granulocytes and nasal responsiveness: A study of the allergic inflammatory reaction in the human nasal mucosa. Thesis. Lund, Sweden, 1991.
5. Andersson M, Andersson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced nasal hyperresponsiveness: Effect of topical glucocorticosteroid treatment. Allergy 44:342-348, 1989.
6. Gerth van Wijk R, Zijlstra FJ, van Toorenenbergen AW, et al. An isolated early response after nasal allergen challenge is sufficient to induce nasal hyperreactivity. Ann Allergy 69:43-47, 1992.
7. Gerth van Wijk R, van Toorenenbergen AW, Zijlstra FJ, et al. Nasal hyperreactivity and its effect on early and late sequelae of nasal challenge with house-dust mite extract. Allergy Proc 14:273-281, 1993.
8. de Graaf-in 't Veld C, Garrelds IM, van Toorenenbergen AW, Gerth van Wijk R. Nasal responsiveness to allergen and histamine in patients with perennial allergic rhinitis with and without a late phase reaction. Thorax 52:143-148, 1997.
9. de Graaf-in 't Veld C, Garrelds IM, Koenders S, Gerth van Wijk R. Relationships between nasal hyperreactivity, mediators, and eosinophils in patients with perennial allergic rhinitis and controls. Clin Exp Allergy 26:903-909, 1996.
10. de Graaf-in 't Veld C, Garrelds IM, Jansen APH, van Toorenenbergen AW, Mulder PGH, Meeuwis J, Gerth van Wijk R. Effect of intranasal fluticasone proprionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with house dust mite allergy. Clin Exp Allergy 25:966-973, 1995.
11. Garrelds IM, de Graaf-in 't Veld C, Jansen APH, Gerth van Wijk R. Effect of fluticasone propionate aqueous nasal spray treatment on platelet activating factor and eiconasoid production by nasal mucosa in patients with house dust mite allergy. Mediators of Inflammation 3:381-385, 1994.
12. Garrelds IM, de Graaf-in 't Veld C, Nahori MA, Vargaftig B, Gerth van Wijk R. Interieukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients. Eur J Pharmacol 275:295-300, 1995.
13. de Graaf-in 't Veld C, Garrelds IM, van Toorenenbergen AW, Mulder PGH, Gerth van Wijk R. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. Ann Allergy Asthma Immunol 75:261-266, 1995.
14. Garrelds IM, de Graaf-in 't Veld C, van Toorenenbergen AW, Gerth van Wijk R, et al. Selective effect of levocabastine on histamine receptor and histamine release from human leucocytes and guinea pig isolated tissue. Ann Allergy Asthma Immunol 76:327-334, 1996.
15. Garrelds IM, van Amsterdam JGC, de Graaf-in 't Veld C, Gerth van Wijk R, et al. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy. Thorax 50:275-279, 1995.
16. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21:77-83, 1991.
17. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 health Status Questionnaire. J Allergy Clin Immunol 94:182-188, 1994.
18. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 93:413-423, 1994.
19. de Graaf-in 't Veld C, Koenders S, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 98:508-513, 1996.